Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial.

Anju Pradhan SinhaSubodh S GuptaRamesh PoluruAbhishek V RautNarendra Kumar AroraRavindra Mohan PandeyAditya Ranjan SahuAdhisivam BethouSunil SazawalSailajanandan ParidaAshish BavdekarArvind SailiRajni GaindArti KapilBishan S GargChetna MaliyeManish JainKamlesh S MahajanPratibha DhingraKeshab C PradhanAnand S KawadeSushma NangiaAjit MukherjeeReeta RasailyRadhey Shyam Sharmanull null

Published in: Trials (2021)

Clinical Trial Registry of India (CTRI) CTRI/2019/05/019197 . Registered on 16 May 2019.

Keyphrases

double blind
phase iii
low birth weight
placebo controlled
clinical trial
preterm infants
phase ii
human milk
preterm birth
open label
study protocol
acute kidney injury
intensive care unit
randomized controlled trial